
MDPC’s New Policy Paper on Parkinson’s Disease Care Access
This month, the Movement Disorder Policy Coalition (MDPC) released a new policy paper, “Parkinson’s Disease:…
This month, the Movement Disorder Policy Coalition (MDPC) released a new policy paper, “Parkinson’s Disease:…
In 2023, Aimed Alliance engaged in a wide variety of activities to protect and enhance…
Senate Commerce Committee leaders, Maria Cantwell and Chuck Grassley, along with 12 lawmakers, are requesting…
Cell and gene therapies (CGTs) have provided new optimism for patients living with diseases previously…
Florida’s plan to import prescription drugs from Canada is facing a potential setback as Canadian…
On January 17, 2024, the Centers for Medicare & Medicaid Services (CMS) finalized the CMS…
On January 22, 2024, Aimed Alliance published two new resources on prescription drug affordability boards…
On January 5, 2024, the U.S. Food and Drug Administration (FDA) approved Florida’s Agency for…
On January 5, 2024, Aimed Alliance submitted a comment on the Medicare Program Contract Year…
On January 8, 2024, Aimed Alliance submitted a comment to the Centers for Medicare and…